ETF Analysis & Opinion

2019 was without doubt a dead year for some of the largest oil and gas producers. Their share prices struggled to break out of a sluggish cycle, triggered by oversupply and concerns about potential...

The Russell 2000 could be on the verge of another rally, as a market recalibration in favor of domestic shares is likely to build on their YTD underperformance. Small cap companies are generally...

Facebook's (NASDAQ:FB) shares have soared this year, signaling that investors are confident the social media giant has successfully overcome the major challenges it was confronting and is now firmly...

America’s largest telecom operator, AT&T (NYSE:T), has proved a profitable bet in 2019. Despite the worries about its future growth and the stiff competitive environment in which it’s...

What people say and what they do often don't align. But that's not the case when it comes to Aurora Cannabis (NYSE:ACB), (TSX:ACB) CEO Terry Booth. The chief executive of the Edmonton-based...

This post was written exclusively for Investing.com The S&P 500 is having a year-end run-up, and now history may be about to repeat itself. As previously noted on Oct. 18, the S&P 500 was...

This post was written exclusively for U.K. Investing.comIn late November thoughts naturally turn to the upcoming new year and investment opportunities ahead. A casual glance at a few of the strategy...

Here’s why U.S. small caps are likely to outperform in the coming weeks and months. Value seekers have been steadily increasing demands for U.S. small caps, taking advantage of lower valuations...

It could be the fact that the calendar year is winding down. Or, it might be the recent volatile seesawing of share prices in the cannabis sector that has market watchers wondering out loud about the...

The recent, astonishing rally in Tesla (NASDAQ:TSLA) shares is faltering. And just like many previous boom-and-bust cycles, the electric carmaker only has itself to blame. Tesla plunged more than 6%...

The biotech sector, as measured by the SPDR S&P Biotech (NYSE:XBI) is staging what could be a massive break out. The ETF has been trending lower since September 2018, with shares of the ETF...

With the third-quarter earnings season almost over, it’s becoming clear that technology companies, which powered the market’s nine-year bull-run, are returning with a roar after a little...

One of the more interesting statistics released this week was the $3 billion equivalent inflow into pan-European equities over the last 2 weeks. Putting an end to a record run of 85 weeks of...

After much talk of an imminent recession, we find ourselves once again back in a roaring bull market. The latest leg higher in equities — which has pushed the benchmark indices to records...